Tuesday, September 14, 2021

Equity Corporate Actions Alert #2021 - 198
Information Regarding the Tender Offer of Translate Bio, Inc. (TBIO)


  • Industry Announcement

Markets Impacted:

Contact Information:


The tender offer by Sanofi (SNY) to acquire all of the outstanding common stock of Translate Bio, Inc. (TBIO) expired at 11:59 p.m. ET, on September 13, 2021. The subsequent merger is became effective on today, September 14, 2021, prior to the market open. The suspension details are as follows:

Company Name/Issue: Translate Bio, Inc. Common Stock
CUSIP: 89374L104
Symbol: TBIO
Offer Price: $38.00 per share held
Marketplace Effective Date for Suspension: September 15, 2021

Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives.

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.